cbdMD Inc., a leading CBD company, reported $4.6 million in revenue for the third quarter of fiscal 2025, a decline from $5.2 million in the same period the previous year. The company's operating loss increased to $0.9 million compared to a $0.4 million loss in the prior year period. The net loss attributable to common shareholders was approximately $1.2 million, or a loss of $0.21 per share, compared to a net loss of about $0.5 million, or $8.93 per share, in the third quarter of fiscal 2024. The company highlighted strategic changes aimed at reversing a multi-year revenue slide, including a major overhaul of its marketing team and digital strategies. cbdMD's beverage brand, Oasis, has expanded its distribution into seven states as of mid-August 2025, showing potential for growth. Despite regulatory challenges impacting revenue, cbdMD remains optimistic about future growth and industry consolidation opportunities. The company is encouraged by national developments such as progress on the farm bill and discussions on cannabis scheduling.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.